Neuropeptide carnosine increases stability of lipoproteins and red blood cells as well as efficiency of immune competent system in patients with chronic discirculatory encephalopathy

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

Volumn 3, Issue 1, 2009, Pages 62-65

  Fedorova, T N ^a   Belyaev, M S ^a   Trunova, O A ^a   Gnezditsky, V V ^a   Maximova, M Yu ^a   Boldyrev, A A ^a  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Carnosine; Chronic discirculatory encephalopathy; Erythrocytes; Lipoproteins; Neuropeptides

Indexed keywords

CARNOSINE; FERROUS ION; LIPOPROTEIN; PROTEIN P300; SEVITINE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ARTICLE; BRAIN DISEASE; CHRONIC DISCIRCULATORY ENCEPHALOPATHY; COGNITION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ERYTHROCYTE; HEMOLYSIS; HUMAN; IMMUNOCOMPETENCE; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 66649108236     PISSN: 19907478     EISSN: 19907494     Source Type: Journal    
DOI: 10.1134/S1990747809010085     Document Type: Article

References (12)

1. Gulevitshch, W.S. and Amiradgibi, S., Uber das Carnosin, eine Neue Organische Base des Flieischextractes, Ber. Deutsch. Chem. Ges., 1900, vol. 33, pp. 1902-1903.
2. Boldyrev, A.A., Karnozin i zashchita tkanei ot okislitel'nogo stressa (Carnosine and Protection of Tissues against Oxidative Stress), Moscow, Dialog-Moscow State University, 1999.
3. Boldyrev, A. Carnosine and Oxidative Stress in Cells and Tissues, N.-Y., Nova Publishers, 2006.
4. Vereshchagin, N.V., Tanashyan, M.M., Fedorova, T.N., and Smirnova, I.N., Antioxidants in Angioneurology, Atmosphere. Neuronal Diseases (Rus.), 2004, no. 3, pp. 8-12.
5. Suslina, Z.A., Fedorova, T.N., Maximova, M.Yu., Ryasina, T.V., Stvolinsky, S.L., Khrapova, E.V., and Boldyrev, A.A., Antioxidant Therapy under Ischemic Stroke, Zhurnal Neurologii i Psykhiatrii (Rus.), 2000, vol. 100, no. 10, pp. 34-38.
6. Fedorova, T.N., Bagyeva, G.Kh., Stepanova, M.S., Dobrotvorskaya, I.C., Ivanova-Smolenskaya, I.A., Polevaya, E.V., Boldyrev, A.A., and Illarioshkin, S.N., Carnosine Increases Efficiency of Drug Therapy at Parkinson Disease, Bekhterev Neurol. Byull. (Rus.), 2008 (in press).
7. Arzumanyan, E.S., Makhro, A.V., Tyulina, O.V., and Boldyrev, A.A., Carnosine Protects Erythrocytes from the Oxidative Stress Caused by Homocysteic Acid, Dokl. RAN, Biochem. Biophys. (Rus.), 2008, vol. 418, pp. 44-46.
8. Stvolinsky, S.L., Sousa-Pontesh, E., Sergienko, V.I., and Boldyrev, A.A., Immune Modulating Effects of Carnosine in Experiments in Vitro and in Vivo, Biol. Membr. (Rus.), 1996, vol. 13, pp. 299-306.
9. Gnezditsky, V.V., Vyzvannye potentsialy mozga v klinicheskoi praktike (Brain Induced Potentials in Clinical Practice), Moscow, MED Press-Inform, 2003.
10. Makhro, A.V., Mashkina, A.P., Solenaya, O.A., Trunova, O.A., Tyulina, O.V., Bulygina, E.R., and Boldyrev, A.A., Carnosine Protects from Oxidative Stress Induced by Hyperhomocysteinemia, Neurokhimia (Rus.), 2008, vol. 25, pp. 233-240.
11. Severin, S.E., Discovery of Carnosine and Anserine. Some Features, Biokhimia (Moscow) (Rus.), 1992, vol. 57, pp. 1285-1295.
12. Zenkov, N.K., Lankin, V.Z., and Menjshikova, E.B., Okislitel'nyi stress. Biokhimicheskie I patofiziologicheskie aspekty (Oxidative Stress. Biochemical and Patophysiological Aspects), Moscow, MAIK (Nauka/ Interperiodika), 2001.